• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

CBI Announces the Agenda for its Forum on FDA's Structured Product Labeling (SPL R4)

Posted on: Tuesday, 29 September 2009, 07:15 CDT

WOBURN, Mass., Sept. 29 /PRNewswire/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their forum on FDA's Structured Product Labeling (SPL R4). The inaugural program will be chaired by Theresa Brunone, Assistant Director, GlaxoSmithKline. The conference will take place in Washington, DC, on December 8-9, 2009.

CBI's speaker faculty always includes the country's leading experts in the bio/pharmaceutical industry and advanced session "SPL Lifecycle Management of Drug Labels" will be a highlight at this timely and relevant event. In addition to targeted 11 sessions and multiple opportunities for networking with industry peers, attendees will have the opportunity to attend a pre-conference workshop -- SPL Primer -- "How to Create, Validate and Submit SPL R4 Documents Successfully."

Top executives from companies such as Amneal Pharmaceuticals, Genzyme, Hoffmann-La Roche, Sanofi-aventis, Watson Pharmaceuticals and Wyeth will assess how to:

• Mitigate financial and regulatory risks through compliance with SPL R4
• Manage overlapping changes to the content of labeling and drug product listing metadata
• Understand where data needs to go and how it works with XML
• Hear about special requirements for veterinary drugs
• Gain tips for working with your vendor in implementing SPL R4
• Learn how to submit through FDA's electronic submission gateway (ESG)
• Obtain the correct D-U-N-S Number for your own establishment and for business
  

The conference is the industry's best opportunity to identify process and technical solutions to gain operational efficiencies and avoid time-to-market delays. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/spl.

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology and medical device industries. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit http://www.cbinet.com.

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Center for Business Intelligence

Source: PR Newswire

More News in this Category